CD16 Monoclonal antibody
CD16 Monoclonal Antibody for IHC, IF-P, ELISA
Host / Isotype
Mouse / IgG1
Reactivity
human
Applications
IHC, IF-P, ELISA and More (1)
Conjugate
Unconjugated
CloneNo.
1E12E11
验证数据展示
经过测试的应用
Positive IHC detected in | human liver tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Positive IF-P detected in | human tonsillitis tissue |
推荐稀释比
Application | Dilution |
---|---|
Immunohistochemistry (IHC) | IHC : 1:2500-1:10000 |
Immunofluorescence (IF)-P | IF-P : 1:200-1:800 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
发表文章中的应用
IHC | See 1 publications below |
IF | See 2 publications below |
产品信息
66779-1-Ig targets CD16 in IHC, IF-P, ELISA applications and shows reactivity with human samples.
Tested Applications | IHC, IF-P, ELISA Application Description |
Cited Applications | IHC, IF |
Tested Reactivity | human |
Cited Reactivity | human |
Immunogen | CD16 fusion protein Ag9787 种属同源性预测 |
Host / Isotype | Mouse / IgG1 |
Class | Monoclonal |
Type | Antibody |
Full Name | Fc fragment of IgG, low affinity IIIa, receptor (CD16a) |
Synonyms | Fc gamma RIII alpha, Fc gamma RIII, CD16-II, CD16a antigen, CD16A |
Calculated Molecular Weight | 254 aa, 29 kDa |
GenBank Accession Number | BC017865 |
Gene Symbol | CD16a |
Gene ID (NCBI) | 2214 |
ENSEMBL Gene ID | ENSG00000203747 |
RRID | AB_2918477 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Protein A purification |
UNIPROT ID | P08637 |
Storage Buffer | PBS with 0.1% sodium azide and 50% glycerol pH 7.3. |
Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
背景介绍
实验方案
Product Specific Protocols | |
---|---|
IHC protocol for CD16 antibody 66779-1-Ig | Download protocol |
IF protocol for CD16 antibody 66779-1-Ig | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
发表文章
Species | Application | Title |
---|---|---|
J Oncol IL-2 Combined with IL-15 Enhanced the Expression of NKG2D Receptor on Patient Autologous NK Cells to Inhibit Wilms' Tumor via MAPK Signaling Pathway | ||
Front Immunol Neoadjuvant immunochemotherapy improves clinical outcomes of patients with esophageal cancer by mediating anti-tumor immunity of CD8+ T (Tc1) and CD16+ NK cells |